Haleon

Haleon is a global leader in consumer health focusing on oral health and medicines.

Lobbying Activity

Meeting with Piotr Müller (Member of the European Parliament, Rapporteur) and Procter & Gamble and

27 Jan 2026 · Omnibus VI

Meeting with Tomislav Sokol (Member of the European Parliament, Shadow rapporteur) and Novo Nordisk A/S and Koninklijke Philips

18 Nov 2025 · Health Policy

Meeting with Olga Solomon (Head of Unit Health and Food Safety) and European Federation of Pharmaceutical Industries and Associations and

3 Oct 2025 · The discussion focused on simplifying Annex II to foster innovation while aligning with ICH guidelines, with ideas for legacy products to gradually transition.

Meeting with Jana Dabbelt (Cabinet of Commissioner Olivér Várhelyi)

2 Jul 2025 · Introduce Haleon, Contribution of self-care sector to resilience of European healthcare systems and public health, - Opportunities for simplification in the healthcare sector

Meeting with Margarita De La Pisa Carrión (Member of the European Parliament)

13 Jun 2025 · Regulación de productos antifúngicos y antimicrobianos

Meeting with Marion Walsmann (Member of the European Parliament) and Bundesverband Öffentlicher Banken Deutschlands eV and McDonald’s Global Franchising Limited

22 May 2025 · Omnibus I

Meeting with Angelika Niebler (Member of the European Parliament)

19 May 2025 · Omnibus I

Meeting with Stine Bosse (Member of the European Parliament, Shadow rapporteur for opinion)

7 May 2025 · Omnibus I proposal

Meeting with Pietro Fiocchi (Member of the European Parliament) and Cosmetics Europe and Association Internationale de la Savonnerie, de la Détergence et des Produits d'Entretien

7 May 2025 · Tematiche ambientali

Meeting with Ilhan Kyuchyuk (Member of the European Parliament)

30 Apr 2025 · presentation of positions on the Omnibus 1 package

Meeting with Hildegard Bentele (Member of the European Parliament, Shadow rapporteur)

28 Apr 2025 · Surface water and groundwater pollutants

Meeting with Laurent Castillo (Member of the European Parliament)

4 Feb 2025 · Automedication

Meeting with Nicolás González Casares (Member of the European Parliament)

21 Jan 2025 · Consumer healthcare medicines and products

Meeting with András Tivadar Kulja (Member of the European Parliament)

20 Jan 2025 · Non-communicable diseases.

Meeting with Ondřej Dostál (Member of the European Parliament)

26 Nov 2024 · Introduction

Meeting with Katarína Roth Neveďalová (Member of the European Parliament)

5 Nov 2024 · Contribution of self-care to healthcare systems and individual wellbeing

Meeting with Nathalie Colin-Oesterlé (Member of the European Parliament) and GSK

19 Feb 2024 · Législation pharmaceutique

Meeting with Pernille Weiss-Ehler (Member of the European Parliament, Rapporteur) and AbbVie and Pharma Deutschland e.V

14 Feb 2024 · Directive on Medicinal products for human use

Meeting with Dolors Montserrat (Member of the European Parliament) and European Confederation of Pharmaceutical Entrepreneurs

28 Nov 2023 · Revision of the pharmaceutical legislation

Haleon urges EU to protect access to non-prescription medicines

6 Nov 2023
Message — Haleon requests increasing data protection for switches to three years. They also support maintaining current marketing authorization pathways. They oppose mandatory prescriptions for common antifungal treatments.123
Why — This would lower development costs and extend market exclusivity for non-prescription medicines.45
Impact — Environmental protection goals may be compromised if product restrictions are significantly delayed.6

Meeting with Erik Poulsen (Member of the European Parliament, Rapporteur)

3 Jul 2023 · NCD

Meeting with Geert Bourgeois (Member of the European Parliament, Shadow rapporteur for opinion)

24 May 2023 · critical raw materials

Meeting with Billy Kelleher (Member of the European Parliament)

15 May 2023 · Pharma Strategy/General business discussion

Haleon calls for harmonised rules and delayed packaging deadlines

13 Mar 2023
Message — Haleon recommends amending the proposal to ensure that national requirements cannot go beyond EU rules. They also request at least ten years for medicine packaging to comply with new recyclability standards.12
Why — Harmonised legislation allows the company to trade across the EU without modifying products.3
Impact — Individual Member States lose authority to mandate specific national environmental labelling requirements.4

Meeting with Ville Niinistö (Member of the European Parliament, Shadow rapporteur)

6 Mar 2023 · Water Framework Directive (staff level)

Meeting with Luisa Regimenti (Member of the European Parliament, Shadow rapporteur) and RELOOP and Suntory Beverage Food Europe

28 Feb 2023 · PPWR

Meeting with César Luena (Member of the European Parliament)

23 Feb 2023 · MEP Luena's team on the upcoming EU Pharmacuetical Strategy

Meeting with Margrete Auken (Member of the European Parliament, Shadow rapporteur)

31 Jan 2023 · Recast of the UWWTD

Meeting with Frances Fitzgerald (Member of the European Parliament)

25 Jan 2023 · Industry priorities

Meeting with Kevin Keary (Cabinet of Executive Vice-President Valdis Dombrovskis)

24 Jan 2023 · pharma trade, supply chain resilience

Meeting with Ivan Štefanec (Member of the European Parliament)

8 Nov 2022 · Packaging, AI Act

Meeting with Maurits-Jan Prinz (Cabinet of Commissioner Thierry Breton)

8 Nov 2022 · Resilience of EU supply chains for the health industrial ecosystem